NICE announces decision on type-2 diabetes treatment

Sitagliptin and vildagliptin have been recommended as alternatives to a sulfonylurea in NICE type-2 diabetes guidelines.

The DPP-4 inhibitors should be considered in patients taking metformin who are unsuitable for treatment with a sulfonylurea, NICE has recommended.

The guidelines also suggest that exenatide should be restricted to use for severely obese patients. The GLP-1 mimetic should only be used for patients with BMIs over 35 who have problems associated with this weight and need to improve their diabetes control, NICE says.

The guidelines also recommend use of pioglitazone or rosiglitazone as second- or third-line treatments and consider the place of long-acting insulin analogues in diabetes treatment.

Dr Amanda Adler, consultant physician at Addenbrooke's Hospital, Cambridge, and guideline development group chairman, said: ‘These guidelines acknowledge that the treatment of type-2 diabetes may require many drugs, often used simultaneously.

‘These guidelines weigh up the effectiveness of these newer agents against older, standard therapies, but also consider side-effects, patient well-being, and whether these newer drugs reflect the best use of NHS resources.'

tom.moberly@haymarket.com

  • What do you think of the new guidelines?

For more information on Guideline summaries, or to view more MIMS drug information please click here.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Breakthrough for state GP indemnity as second MDO agrees terms on historic liabilities

Breakthrough for state GP indemnity as second MDO agrees terms on historic liabilities

A second medical defence organisation (MDO) has agreed terms for the government to...

Labour pledges to boost GP training places by 50%

Labour pledges to boost GP training places by 50%

The Labour party has announced plans to increase the number of GP trainees in England...

Northern Ireland unveils £27m GP funding boost for 2019/20

Northern Ireland unveils £27m GP funding boost for 2019/20

Investment in general practice in Northern Ireland will rise by £26.76m during the...

'How I survived a bewildering ten-month investigation by the GMC'

'How I survived a bewildering ten-month investigation by the GMC'

How does the experience of a GMC investigation impact on the lives of doctors? One...

90% of patients would recommend their GP practice to friends or family

90% of patients would recommend their GP practice to friends or family

Nine in 10 people would recommend their GP practice to a friend or family member,...

NHS documentary spells out threat to future of the health service

NHS documentary spells out threat to future of the health service

A documentary film appearing in cinemas across the UK next month tells how the NHS...